Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 18, 2025
Stem
cell-derived
extracellular
vesicles
(EVs)
have
emerged
as
a
safe
and
potent
alternative
to
regenerative
medicine
in
recent
decades.
Furthermore,
the
adjustment
of
EV
functions
has
been
recently
enabled
by
certain
stem
cell
preconditioning
methods,
providing
an
exceptional
opportunity
enhance
therapeutic
potential
or
confer
additional
EVs.
In
this
review,
we
discuss
progress
functionalized
EVs,
based
on
preconditioning,
for
treating
various
organ
systems,
such
musculoskeletal
system,
nervous
integumentary
cardiovascular
renal
respiratory
system.
Additionally,
summarize
expected
outcomes
methods
cells
their
With
progress,
suggest
considerations
future
directions
developing
personalized
preconditioned
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: July 20, 2023
Abstract
Extracellular
vesicles
(EVs)
are
nano-sized,
natural,
cell-derived
that
contain
the
same
nucleic
acids,
proteins,
and
lipids
as
their
source
cells.
Thus,
they
can
serve
natural
carriers
for
therapeutic
agents
drugs,
have
many
advantages
over
conventional
nanocarriers,
including
low
immunogenicity,
good
biocompatibility,
blood
–
brain
barrier
penetration,
capacity
gene
delivery.
This
review
first
introduces
classification
of
EVs
then
discusses
several
currently
popular
methods
isolating
purifying
EVs,
EVs-mediated
drug
delivery,
functionalization
carriers.
Thereby,
it
provides
new
avenues
development
EVs-based
strategies
in
different
fields
medicine.
Finally,
highlights
some
challenges
future
perspectives
with
regard
to
clinical
application
EVs.
Graphical
Pharmacological Reviews,
Journal Year:
2023,
Volume and Issue:
75(5), P. 1043 - 1061
Published: June 6, 2023
Extracellular
vesicles
(EVs)
are
cell-derived
membrane
enclosed
particles
that
involved
in
physiological
and
pathological
processes.
EVs
increasingly
being
studied
for
therapeutic
applications
the
field
of
regenerative
medicine.
Therapeutic
application
stem
has
shown
great
potential
to
stimulate
tissue
repair.
However,
exact
mechanisms
through
which
they
induce
this
effect
not
been
fully
clarified.
This
may
a
large
extent
be
attributed
lack
knowledge
on
EV
heterogeneity.
Recent
studies
suggest
represent
heterogeneous
population
with
distinct
functions.
The
heterogeneity
can
differences
their
biogenesis,
as
such,
classified
into
populations
then
further
subcategorized
various
subpopulations.
A
better
understanding
is
crucial
elucidating
action
regeneration.
review
provides
an
overview
latest
insights
related
repair,
including
different
characteristics
contribute
such
heterogeneity,
well
functional
among
subtypes.
It
also
sheds
light
challenges
hinder
clinical
translation
EVs.
Additionally,
innovative
isolation
techniques
studying
discussed.
Improved
active
subtypes
would
promote
development
tailored
therapies
aid
researchers
EV-based
therapeutics
clinic.
Significance
Statement
Within
we
discuss
properties
subpopulations,
implications
therapeutics.
We
aim
provide
new
aspects
leading
preparations,
stress
importance
applications.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(4), P. 1264 - 1285
Published: Jan. 1, 2023
With
the
increase
of
population
aging,
number
Alzheimer's
disease
(AD)
patients
is
also
increasing.According
to
current
estimates,
approximately
11%
people
over
65
suffer
from
AD,
and
that
percentage
rises
42%
among
85.However,
no
effective
treatment
capable
decelerating
or
stopping
AD
progression
available.Furthermore,
AD-targeted
drugs
composed
synthetic
molecules
pose
concerns
regarding
biodegradation,
clearance,
immune
response,
neurotoxicity.Mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs)
are
essential
intercellular
communication
mediators
holding
great
promise
as
therapeutics
owing
their
biocompatibility,
versatility,
effortless
storage,
superior
safety,
ability
transport
messenger
noncoding
RNAs,
proteins,
lipids,
DNAs,
other
bioactive
compounds
derived
cells.The
functionalisation
engineering
strategies
MSC-EVs
highlighted
(e.g.preconditioning,
drug
loading,
surface
modification,
artificial
EV
fabrication),
which
could
improve
by
multiple
therapeutic
effects,
including
clearing
abnormal
protein
accumulation
achieving
neuroprotection
immunomodulatory
effects.Herein,
this
review
summarises
state-of-the-art
engineer
MSC-EVs,
discusses
progress
in
use
therapeutics,
presents
perspectives
challenges
associated
with
related
clinical
applications,
concludes
engineered
show
immense
potential
therapy.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 28, 2024
Malignancy
is
a
major
public
health
problem
and
among
the
leading
lethal
diseases
worldwide.
Although
current
tumor
treatment
methods
have
therapeutic
effect
to
certain
extent,
they
still
some
shortcomings
such
as
poor
water
solubility,
short
half-life,
local
systemic
toxicity.
Therefore,
how
deliver
agent
so
realize
safe
effective
anti-tumor
therapy
become
urgently
be
solved
in
this
field.
As
medium
of
information
exchange
material
transport
between
cells,
exosomes
are
considered
promising
drug
delivery
carrier
due
their
nano-size,
good
biocompatibility,
natural
targeting,
easy
modification.
In
review,
we
summarize
recent
advances
isolation,
identification,
loading,
modification
carriers
for
alongside
application
therapy.
Basic
knowledge
exosomes,
biogenesis,
sources,
characterization
methods,
also
introduced
herein.
addition,
challenges
related
use
vehicles
discussed,
along
with
future
trends.
This
review
provides
scientific
basis
exosome
systems
oncological
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(5), P. 2099 - 2126
Published: Jan. 1, 2024
Exosomes,
which
are
small
vesicles
enclosed
by
a
lipid
bilayer
and
released
many
cell
types,
widely
dispersed
have
garnered
increased
attention
in
the
field
of
regenerative
medicine
due
to
their
ability
serve
as
indicators
diseases
agents
with
therapeutic
potential.
Exosomes
play
crucial
role
mediating
intercellular
communication
through
transfer
biomolecules,
including
proteins,
lipids,
RNA,
other
molecular
constituents,
between
cells.
The
targeted
transport
proteins
nucleic
acids
specific
cells
has
potential
enhance
or
impair
biological
functions.
applications,
they
can
be
used
alone
combination
approaches.
examination
unique
attributes
functions
these
factors
emerged
prominent
study
realm
biomedical
research.
This
manuscript
summarizes
origins
properties
exosomes,
structural,
biological,
physical,
chemical
aspects.
paper
offers
complete
recent
progress
tissue
repair
medicine,
emphasizing
possible
implications
methods
forthcoming
regeneration
attempts.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(12), P. 6480 - 6480
Published: June 9, 2022
Extracellular
vesicles
(EVs)
are
lipid
bilayer
membrane
particles
that
play
critical
roles
in
intracellular
communication
through
EV-encapsulated
informative
content,
including
proteins,
lipids,
and
nucleic
acids.
Mesenchymal
stem
cells
(MSCs)
pluripotent
with
self-renewal
ability
derived
from
bone
marrow,
fat,
umbilical
cord,
menstruation
blood,
pulp,
etc.,
which
they
use
to
induce
tissue
regeneration
by
their
direct
recruitment
into
injured
tissues,
the
heart,
liver,
lung,
kidney,
or
secreting
factors,
such
as
vascular
endothelial
growth
factor
insulin-like
factor.
Recently,
MSC-derived
EVs
have
been
shown
regenerative
effects
against
various
diseases,
partially
due
post-transcriptional
regulation
of
target
genes
miRNAs.
Furthermore,
garnered
attention
novel
drug
delivery
systems,
because
can
specially
encapsulate
molecules.
In
this
review,
we
summarize
molecular
mechanisms
EVs.
Membranes,
Journal Year:
2022,
Volume and Issue:
12(8), P. 739 - 739
Published: July 28, 2022
Osteoarthritis
(OA)
is
characterized
by
progressive
cartilage
degeneration
with
increasing
prevalence
and
unsatisfactory
treatment
efficacy.
Exosomes
derived
from
mesenchymal
stem
cells
play
an
important
role
in
alleviating
OA
promoting
regeneration,
inhibiting
synovial
inflammation
mediating
subchondral
bone
remodeling
without
the
risk
of
immune
rejection
tumorigenesis.
However,
low
yield,
weak
activity,
inefficient
targeting
ability
unpredictable
side
effects
natural
exosomes
have
limited
their
clinical
application.
At
present,
various
approaches
been
applied
exosome
engineering
to
regulate
production
function,
such
as
pretreatment
parental
cells,
drug
loading,
genetic
surface
modification.
Biomaterials
also
proved
facilitate
efficient
delivery
enhance
effectiveness.
Here,
we
summarize
current
understanding
biogenesis,
isolation
characterization
exosomes,
focus
on
large-scale
preparation
engineered
well
therapeutic
potential
OA,
thus
providing
novel
insights
into
exploring
advanced
MSC-derived
exosome-based
cell-free
therapy
for
OA.
Bioactive Materials,
Journal Year:
2024,
Volume and Issue:
38, P. 258 - 275
Published: May 7, 2024
Microorganisms,
physical
factors
such
as
temperature
or
mechanical
injury,
and
chemical
free
monomers
from
composite
resin
are
the
main
causes
of
dental
pulp
diseases.
Current
clinical
treatment
methods
for
diseases
include
root
canal
therapy,
vital
therapy
regenerative
endodontic
therapy.
Regenerative
serves
purpose
inducing
regeneration
new
functional
tissues
through
autologous
revascularization
tissue
engineering.
This
article
first
discusses
current
reviews
strategies
well
research
outcomes
regarding
regeneration.
Then
in
vivo
models,
prospects
challenges
were
further
discussed.
Regenerative Therapy,
Journal Year:
2024,
Volume and Issue:
26, P. 260 - 274
Published: June 1, 2024
Chronic
wounds
represent
a
significant
global
burden,
afflicting
millions
with
debilitating
complications.
Despite
standard
care,
impaired
healing
persists
due
to
factors
like
persistent
inflammation
and
tissue
regeneration.
Mesenchymal
stem
cell
(MSC)-derived
extracellular
vesicles
(EVs)
offer
an
innovative
regenerative
medicine
approach,
delivering
cell-derived
therapeutic
cargo
in
engineered
nanoscale
delivery
systems.
This
review
examines
pioneering
bioengineering
strategies
engineer
MSC-EVs
into
precision
nanotherapeutics
for
chronic
wounds.
Emerging
technologies
CRISPR
gene
editing,
microfluidic
manufacturing,
biomimetic
systems
are
highlighted
their
potential
enhance
MSC-EV
targeting,
optimize
enrichment,
ensure
consistent
clinical-grade
production.
However,
key
hurdles
remain,
including
batch
variability,
rigorous
safety
assessment
tumorigenicity,
immunogenicity,
biodistribution
profiling.
Crucially,
collaborative
frameworks
harmonizing
regulatory
science
patient
advocacy
hold
the
expediting
clinical
translation.
By
overcoming
these
challenges,
could
catalyze
new
era
of
off-the-shelf
therapies,
restoring
hope
afflicted
by
non-healing
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(8), P. 3358 - 3384
Published: Jan. 1, 2024
With
the
increase
in
aging
population,
occurrence
of
neurological
disorders
is
rising.Recently,
stem
cell
therapy
has
garnered
attention
due
to
its
convenient
sourcing,
minimal
invasiveness,
and
capacity
for
directed
differentiation.However,
there
are
some
disadvantages,
such
as
poor
quality
control,
safety
assessments,
ethical
logistical
issues.Consequently,
scientists
have
started
shift
their
from
cells
extracellular
vesicles
similar
structures
properties.Beyond
these
parallels,
can
enhance
biocompatibility,
facilitate
easy
traversal
barriers,
minimize
side
effects.Furthermore,
cell-derived
be
engineered
load
drugs
modify
surfaces
treatment
outcomes.In
this
review,
we
summarize
functions
native
vesicles,
subsequently
review
strategies
engineering
applications
Alzheimer's
disease,
Parkinson's
stroke,
discuss
challenges
solutions
associated
with
clinical
translation
vesicles.